Binimetinib, sold under the brand name Mektovi, is an anti-cancer medication used to treat various cancers. [4] Binimetinib is a selective inhibitor of MEK, a central kinase in the tumor …

2024年1月31日 · Binimetinib is used in combination with encorafenib to treat melanoma (skin cancer) that has spread or cannot be removed by surgery. It is only used if the melanoma cells …

2024年4月25日 · What is binimetinib? Binimetinib is used in combination with another medicine called encorafenib to treat melanoma (skin cancer) in people who have a "BRAF" gene …

BINIMETINIB (bin i me ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat melanoma.

Binimetinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Read the Medication Guide and, if available, the Patient...

Binimetinib is used along with encorafenib (Braftovi) to treat certain types of non-small cell lung cancer (a type of lung cancer) that has spread to other parts of the body. Binimetinib is in a …

2023年11月16日 · Binimetinib is an anticancer (antineoplastic) medication used in combination with encorafenib in the treatment of adults with melanoma, a type of skin cancer, and non …

MEKTOVI® is indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by …

An orally available inhibitor of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2) with potential antineoplastic activity. Binimetinib, noncompetitive with ATP, binds to and inhibits the …

Binimetinib is approved to be used with encorafenib to treat patients whose cancer has a certain mutation in the BRAF gene, including: Melanoma that cannot be removed by surgery or has …